Elkamshoushi AAM, et al. - Authors evaluated whether or not endocan was a serum marker for cardiovascular risk in erectile dysfunction patients. Thirty patients with erectile dysfunction and 15 controls were enrolled in the study. Findings suggested a probable correlation of serum endocan with ED severity and carotid intima-media thickness (cIMT). Moreover, in ED patients, it has a predictive value for cardiovascular risk. In order to predict the cIMT in ED patients with 83.33% sensitivity and 66.67% specificity, a serum endocan cut-off point of > 2,392.7 ng/ml was yielded by ROC curve assessment.